Gene ID | Gene Name | Gene Symbol | Disease Ontology ▲ |
---|---|---|---|
124281662 | chondroitin sulfate synthase 2-like |
|
|
124253766 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like |
|
|
124286678 | fringe glycosyltransferase-like |
|
|
124269761 | GDP-fucose protein O-fucosyltransferase 1-like |
|
|
124285128 | galactoside 2-alpha-L-fucosyltransferase SEC1-like |
|
|
124254161 | UDP-glucuronosyltransferase 1-2-like |
|
|
124257001 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like |
|
|
124264920 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-B-like |
|
|
124268446 | polypeptide N-acetylgalactosaminyltransferase 2-like |
|
|
124290545 | probable C-mannosyltransferase DPY19L3 |
|
|
124264437 | EGF domain-specific O-linked N-acetylglucosamine transferase-like |
|
|
124281314 | probable N-acetylgalactosaminyltransferase 9 |
|
|
124280858 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase-like |
|
|
124277484 | ribitol-5-phosphate xylosyltransferase 1-like |
|
|
124280169 | carbohydrate sulfotransferase 1-like |
|
|
124269294 | xylosyltransferase oxt-like |
|
|
124264916 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like |
|
|
124287112 | dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase-like |
|
|
124269486 | beta-1,4-galactosyltransferase 1-like |
|
|
124277915 | protein O-mannosyl-transferase TMTC4-like |
|
|
124253015 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase-like |
|
|
124276672 | inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 |
|
|
124268717 | beta-1,3-galactosyltransferase 5-like |
|
|
124266450 | UDP-glucuronosyltransferase 2B31-like |
|
|
124277876 | protein O-mannosyl-transferase TMTC4-like |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024